Insulin therapy in type-2 diabetes

Insulin therapy is often required, but this effective therapy can be improved. By Dr Paula Hensler

Insulin adherence is a challenge (Photograph: SPL)
Insulin adherence is a challenge (Photograph: SPL)

The incidence of type-2 diabetes is increasing worldwide and appropriate and timely methods of management are often debated.

Eventually most patients with type-2 diabetes require insulin to achieve or maintain their ideal HbA1c, however patient concerns and problems with adherence remain.

A recent study by a group of multidisciplinary diabetes experts, who are members of a diabetes consensus group, looked specifically at diabetes care in primary care. They found that while insulin is the most effective treatment in type-2 diabetes, its use remains challenging and time consuming, especially at the time of insulin initiation in primary care.1

They also acknowledged that late insulin initiation may be the result of a lack of consensus between national and international guidelines regarding glycaemic targets and recommendations for optimal diabetes management.

Empowering patients
The authors found that empowering patients through education and self-management is key to improving adherence to insulin therapy and achieving effective long-term glycaemic control. They emphasised the need for developing new insulins with better medication adherence profiles and improved dose flexibility, as well as reduced risk of hypoglycaemia and weight gain and reduced frequency of monitoring and dose adjustment.

Improving insulin therapy adherence

  • Involve patients in treatment decisions to enhance patient self-management. This improves treatment adherence, glycaemic control and patient quality of life.
  • Help patients become knowledgeable about their disease by ensuring you provide information during the consultation. The authors also suggest that providing reading materials, online resources or even structured educational programmes is beneficial but they acknowledge that these approaches are more resource intensive.
  • Understand the patient's priorities and how to make treatments more acceptable.
  • Strategies, such as providing detailed patient information, counselling, reminders and close follow-up, are successful but, again, involve frequent patient interactions and resources.

 

Conclusion
The researchers concluded that a similar approach could be applied to other chronic diseases with an emphasis on resource management, empowering patients and improving adherence to therapy.

Reference
1. Brunton S, Gough S, Hicks D et al. A look into the future: improving diabetes care by 2015. Curr Med Res Opin 2011; 27: S3, 65-72.

Diabetes CPD modules

To learn more about diabetes and insulin therapy and test your knowledge of this area, visit mycme.com/diabetes

These exclusive insulin therapy learning modules cover topics such as the importance of hypoglycaemia, timely insulin initiation and the complications of diabetes.

  • Complete the modules.
  • Gain certificates as evidence of learning.
  • Earn CPD credits.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

BMA suspends GP committee election to investigate potential rule breach

BMA suspends GP committee election to investigate potential rule breach

The BMA has suspended voting in part of its GP committee election as it investigates...

Thousands of overseas GPs recognised for 'extraordinary contribution' to NHS

Thousands of overseas GPs recognised for 'extraordinary contribution' to NHS

GP leaders have recognised the extraordinary contribution of thousands of overseas-qualified...

GPs report concerns over BMA GP committee elections

GPs report concerns over BMA GP committee elections

Elections for nearly one in four regional BMA GP committee seats are underway, but...

UK hits 1m second doses of COVID-19 vaccine as campaign shifts to next phase

UK hits 1m second doses of COVID-19 vaccine as campaign shifts to next phase

More than 1m people UK-wide have now had two doses of COVID-19 vaccine, official...

What GPs need to know about the GMC's new guidance on prescribing

What GPs need to know about the GMC's new guidance on prescribing

MDU medico-legal adviser Kathryn Leask explains the key issues GPs need to be aware...